All Stories

  1. Glucolipotoxicity diminishes cardiomyocyte TFEB and inhibits lysosomal autophagy during obesity and diabetes
  2. Regulation of Autotaxin and its Role in Obesity-Induced Tissue Insulin Resistance
  3. Lipid metabolism and signaling in cardiac lipotoxicity
  4. Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy
  5. New Atglistatin closely related analogues: Synthesis and structure-activity relationship towards adipose triglyceride lipase inhibition
  6. Serum Autotaxin/ENPP2 correlates with insulin resistance in older humans with obesity
  7. Serum autotaxin is independently associated with hepatic steatosis in women with severe obesity
  8. Myocardial Metabolic Abnormalities and Cardiac Dysfunction
  9. AMPK-Dependent Inhibitory Phosphorylation of ACC Is Not Essential for Maintaining Myocardial Fatty Acid Oxidation
  10. The role of ubiquitin ligases in cardiac disease
  11. Cardiomyocyte-specific ablation of CD36 improves post-ischemic functional recovery
  12. Hypoxic Regulation of Hand1 Controls the Fetal-Neonatal Switch in Cardiac Metabolism
  13. Skeletal Muscle Triacylglycerol Hydrolysis Does Not Influence Metabolic Complications of Obesity
  14. Cardiac-specific adipose triglyceride lipase overexpression protects from cardiac steatosis and dilated cardiomyopathy following diet-induced obesity
  15. Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation
  16. Cardiomyocyte specific adipose triglyceride lipase overexpression prevents doxorubicin induced cardiac dysfunction in female mice
  17. Myocardial triacylglycerol metabolism
  18. Myocardial Adipose Triglyceride Lipase Overexpression Protects Diabetic Mice From the Development of Lipotoxic Cardiomyopathy
  19. Enhanced recovery from ischemia–reperfusion injury in PI3Kα dominant negative hearts: Investigating the role of alternate PI3K isoforms, increased glucose oxidation and MAPK signaling
  20. Infarct-remodelled hearts with limited oxidative capacity boost fatty acid oxidation after conditioning against ischaemia/reperfusion injury
  21. Myocardial ATGL Overexpression Decreases the Reliance on Fatty Acid Oxidation and Protects against Pressure Overload-Induced Cardiac Dysfunction
  22. Relationship of glucose and oleate metabolism to cardiac function in lipin-1 deficient (fld) mice
  23. 289 Cardiomyocyte-specific ATGL over-expression prevents doxorubicin-induced cardiac dysfunction in mice
  24. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
  25. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization
  26. Adipose triglyceride lipase plays a key role in the supply of the working muscle with fatty acids
  27. Direct Regulation of Myocardial Triglyceride Metabolism by the Cardiomyocyte Circadian Clock
  28. Adipose Triglyceride Lipase Deficiency Causes Tissue-specific Changes in Insulin Signaling
  29. Mammalian patatin domain containing proteins: a family with diverse lipolytic activities involved in multiple biological functions
  30. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores
  31. Identification of an Insulin-regulated Lysophospholipase with Homology to Neuropathy Target Esterase
  32. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome